Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Dragonboat Biopharmaceutical Company Limited

Clinical trials sponsored by Dragonboat Biopharmaceutical Company Limited, explained in plain language.

Not yet recruiting 1

New drug trial aims to slow scarring in lungs

Disease control Not yet recruiting

This study is testing an investigational drug called BC006 in people with idiopathic pulmonary fibrosis (IPF), a serious lung scarring disease. Over 24 weeks, researchers will compare BC006 against a placebo in 96 participants to see if it can help slow the decline in lung functi…

Phase: PHASE2 • Sponsor: Dragonboat Biopharmaceutical Company Limited • Aim: Disease control

Last updated Apr 02, 2026 14:57 UTC